Psychedelic medicine pioneer exits MDMA biotech after regulatory blow
Psychedelic medicine pioneer, Rick Doblin, has left the MDMA biotech company, MAPS, following a regulatory setback. This decision comes after ...
Psychedelic medicine pioneer, Rick Doblin, has left the MDMA biotech company, MAPS, following a regulatory setback. This decision comes after ...
This week, a heat wave hit the Gaza Strip, with temperatures reaching over 100 degrees Fahrenheit for the past few ...
The Royal New Zealand College of General Practitioners has opened applications for doctors wanting to specialise in general practice (GPEP) ...
Copyright © 2026 News Wave
News Wave is not responsible for the content of external sites.